FormWeb • famotidine

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

Famotidine

famotidine

Formulary H2 - Receptor Blocker Formulary
Formulary Miscellaneous Program Formulary
Restricted Pepcid AC --> Restricted to NO SUB orders.

Drug Name	Form	Strength
Pepcid	SOLUTION, INTRAVENOUS	20 mg/50 mL, 10 mg/mL
Pepcid AC	TABLET, ORAL	10 mg
Pepcid	TABLET, ORAL	20 mg, 40 mg

VIEW MORE Histamine H2-Antagonists
CLASS

Comments:

ORDER FORMULATION

THERAPEUTIC INTERCHANGE

famotidine (Pepcid AC) OTC

10 mg BID

cimetidine (Tagamet)

200 mg BID

Automatic IV to PO conversion per IV to oral conversion guidelines. IV to PO Conversion Guidelines

Automatic renal adjustment per guidelines. Renal Adjustment Guidelines See H2-Receptor Blocker Formulary document for renal dosing recommendations.

Use tablets (to be crushed) instead of famotidine suspension.

If H2 blocker prescribed with PPO, discontinue H2 blocker after 48 hours. Exception if GI physician -- check with physician that H2 blocker is not being used for a non-GI use prior to discontinuing.

Reviewed: 26 Sept 2017 (Renal Adjustment Update)

Last updated: Mar. 1, 2018

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.